Methotrexate and Carbidopa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methotrexate (methotrexate sodium) and Carbidopa (carbidopa). Common drug interactions include haemoglobin decreased among females and arterial occlusive disease among males.

The phase IV clinical study analyzes what interactions people have when they take Methotrexate and Carbidopa. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,314 Methotrexate users. Check the latest studies of Methotrexate.

What is Carbidopa?

Carbidopa has active ingredients of carbidopa. It is often used in parkinson's disease. eHealthMe is studying from 3,061 Carbidopa users. Check the latest studies of Carbidopa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

43 people who take Methotrexate and Carbidopa together, and have interactions are studied.

Methotrexate and Carbidopa drug interactions.

What are the common drug interactions of Methotrexate and Carbidopa, by gender? *:

female:

  1. Haemoglobin decreased
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Pneumonia
  4. Drug hypersensitivity
  5. Large intestinal ulcer
  6. Acute respiratory failure
  7. Anaemia (lack of blood)
  8. Death
  9. Dizziness
  10. Lower gastrointestinal haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding)

male:

  1. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  2. Arthralgia (joint pain)
  3. Hallucination (an experience involving the perception of something not present)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypertension (high blood pressure)
  6. Joint swelling
  7. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Pneumonia
  10. Pyrexia (fever)

What are the common drug interactions of Methotrexate and Carbidopa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  2. Arthralgia (joint pain)
  3. Blood cholesterol increased
  4. Chronic kidney disease
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Hyperhidrosis (abnormally increased sweating)
  7. Hypertension (high blood pressure)
  8. Joint swelling
  9. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

60+:

  1. Haemoglobin decreased
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Vomiting
  4. Anxiety
  5. Arthralgia (joint pain)
  6. Blood magnesium decreased
  7. Blood potassium decreased
  8. Chills (felling of cold)
  9. Cholecystitis (infection of gallbladder)
  10. Cholecystitis infective (infection of gallbladder capable to infect other organs)

What are the existing conditions these people have? *

  1. Pain: 8 people, 18.60%
  2. Irritable Bowel Syndrome: 5 people, 11.63%
  3. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 11.63%
  4. Gout (uric acid crystals building up in the body): 5 people, 11.63%
  5. Constipation: 5 people, 11.63%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 11.63%
  7. Swelling: 4 people, 9.30%
  8. Sleep Disorder: 4 people, 9.30%
  9. Retinal Vessel Occlusion (a blockage in one of the small arteries): 4 people, 9.30%
  10. Osteoporosis (bones weak and more likely to break): 4 people, 9.30%

* Approximation only. Some reports may have incomplete information.

Do you take Methotrexate and Carbidopa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methotrexate and Carbidopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Carbidopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carbidopa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methotrexate sodium and carbidopa (the active ingredients of Methotrexate and Carbidopa, respectively), and Methotrexate and Carbidopa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: